Sol Gel Technologies Ltd (SLGL) is in the middle of the biotechnology industry according to InvestorsObserver. SLGL received an overall rating of 51, meaning it scores above 51% of all actions. Sol Gel Technologies Ltd also scored 57 in the biotech industry, putting it above 57% of biotech stocks. Biotechnology is ranked 34th out of 148 industries.
What do these notes mean?
Finding the best stocks to invest in can be difficult. There are thousands of options and it can be confusing to know what really constitutes great value. InvestorsObserver lets you choose from eight unique metrics to display the top industries and top performing stocks within that industry. A score of 51 would be higher than 51% of all actions. These scores are not only easy to understand, but it’s also easy to compare stocks to each other. You can find the top stocks in an industry or find the sector with the highest average score. The overall score is a combination of technical and fundamental factors that provides a good starting point when analyzing a security. Traders and investors with different goals may have different goals and will want to consider other factors than just the overall number before making investment decisions.
What’s going on with Sol Gel Technologies Ltd shares today?
Sol Gel Technologies Ltd (SLGL) stock is up 1.92% while the S&P 500 is down -0.32% at 2:13 p.m. Wednesday, January 25. SLGL was up $0.10 from the previous closing price of $5.21 on volume of 3,951 shares. . Over the past year, the S&P 500 is down -8.09% while SLGL is down -23.93%. SLGL has earned $0.16 per share over the past 12 months, giving it a price-earnings ratio of 32.54. Click here for the full Sol Gel Technologies Ltd stock report.
Stay in the know
Subscribe to our daily morning update newsletter and never miss market news, moves and more.